A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

The Journal of infectious diseases(2016)

引用 45|浏览61
暂无评分
摘要
NCT01782300.
更多
查看译文
关键词
clinical trial,dengue vaccine,live attenuated tetravalent
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要